Keros Therapeutics Inc (KROS)

Cash & Short-Term Investments

$257.61M

Quarterly · Period ending: · USD

KROS logo

KROS Cash & Short-Term Investments

Latest reported$257.61M
KROS Quarterly Cash & Short-Term Investments ($23.26M → $257.61M)
High-resolution chart · PNG

KROS cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
257,606,000
281,497,000
287,415,000
693,472,000
690,215,000
720,541,000
559,931,000
530,684,000
405,863,000
442,443,000
331,147,000
287,893,000
322,026,000
351,429,000
279,048,000
239,426,000
215,621,000
228,586,000
230,042,000
221,349,000
237,113,000
255,203,000
265,876,000
133,810,000
144,687,000
54,518,000
7,020,000
23,259,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.